Marion McCourt

Marion McCourt, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Regeneron Pharmaceuticals, Inc. and Medivation, Inc. We count 58 filings; the first trade dates from 3 February 2016 and the latest from 3 September 2026.

Sales make up the whole of the open-market record (12 sales, €4.5M). Other entries cover 12 share grants and 34 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

Most recently, on 3 September 2026, the filings show an open-market sale worth €892k in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.